Stay updated on Deflazacort vs Prednisolone in ABPA Clinical Trial
Sign up to get notified when there's something new on the Deflazacort vs Prednisolone in ABPA Clinical Trial page.

Latest updates to the Deflazacort vs Prednisolone in ABPA Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated to version 2.16.5, and the previous version 2.16.4 has been removed. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference1%
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1.0%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check69 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check84 days agoChange DetectedThe page has undergone significant content removal regarding the treatment and understanding of Allergic Bronchopulmonary Aspergillosis (ABPA), including detailed information about glucocorticoids and the introduction of deflazacort as a treatment option. Additionally, a new version number for the document has been added.SummaryDifference39%
Stay in the know with updates to Deflazacort vs Prednisolone in ABPA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deflazacort vs Prednisolone in ABPA Clinical Trial page.